Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Apr 02, 2025 | Apr 04, 2025 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $3.43 | $37,336 | -2.46% |
Feb 20, 2025 | Feb 24, 2025 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $4.24 | $49,616 | -2.58% |
Feb 11, 2025 | Feb 12, 2025 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $4.45 | $74,066 | -5.12% |
Apr 02, 2024 | Apr 03, 2024 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $9.86 | $119,454 | -3.62% |
Feb 21, 2024 | Feb 22, 2024 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $7.46 | $97,226 | -3.75% |
Apr 03, 2023 | Apr 05, 2023 | Sandrock Alfred Pres CEO | Sell | Voyager Therapeutics, Inc. | VYGR | $7.83 | $58,232 | -3.35% |
Jun 07, 2021 | Jun 09, 2021 | Sandrock Alfred Head of Research Development | Sell | Biogen Inc. | BIIB | $440 | $3M | -43.00% |
Nov 04, 2020 | Nov 07, 2020 | Sandrock Alfred EVP Research Development | Sell | Biogen Inc. | BIIB | $350 | $525,000 | -10.30% |
Feb 27, 2018 | Feb 28, 2018 | Sandrock Alfred EVP Chief Medical Officer | Sell | Biogen Inc. | BIIB | $290.83 | $75,325 | -3.80% |
Feb 23, 2018 | Feb 27, 2018 | Sandrock Alfred EVP Chief Medical Officer | Sell | Biogen Inc. | BIIB | $293.44 | $266,444 | -11.76% |
Feb 20, 2018 | Feb 21, 2018 | Sandrock Alfred EVP Chief Medical Officer | Sell | Biogen Inc. | BIIB | $292 | $216,956 | -10.18% |
Feb 15, 2018 | Feb 21, 2018 | Sandrock Alfred EVP Chief Medical Officer | Sell | Biogen Inc. | BIIB | $298.85 | $386,712 | -15.06% |
Apr 03, 2017 | Apr 04, 2017 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $274.08 | $542,952 | -21.91% |
Mar 01, 2017 | Mar 03, 2017 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $290.07 | $282,238 | -9.72% |
Feb 25, 2016 | Feb 26, 2016 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $261.9 | $47,928 | -2.24% |
Feb 17, 2016 | Feb 19, 2016 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $256.16 | $184,948 | -8.29% |
Feb 09, 2016 | Feb 10, 2016 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $246.54 | $210,052 | -9.92% |
Dec 04, 2015 | Dec 07, 2015 | Sandrock Alfred EVP CMO Neuro Neurodegenerat | Sell | Biogen Inc. | BIIB | $277 | $122,157 | -5.39% |
Mar 27, 2015 | Mar 30, 2015 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Inc. | BIIB | $430.12 | $184,952 | -4.78% |
Mar 02, 2015 | Mar 03, 2015 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $409.49 | $1M | -26.06% |
Feb 17, 2015 | Feb 18, 2015 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $389.11 | $162,648 | -2.71% |
Feb 10, 2015 | Feb 11, 2015 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $398.11 | $455,039 | -7.27% |
Feb 09, 2015 | Feb 10, 2015 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $398.05 | $340,731 | -5.17% |
Dec 04, 2014 | Dec 05, 2014 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $345.88 | $152,187 | -2.93% |
Mar 04, 2014 | Mar 05, 2014 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $342.58 | $1M | -17.07% |
Feb 26, 2014 | Feb 27, 2014 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $342.17 | $358,594 | -4.67% |
Feb 13, 2014 | Feb 14, 2014 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $316.42 | $134,478 | -1.95% |
Feb 11, 2014 | Feb 12, 2014 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $314.31 | $655,336 | -13.24% |
Dec 04, 2013 | Dec 05, 2013 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $285.9 | $125,510 | -3.11% |
Oct 22, 2013 | Oct 23, 2013 | Sandrock Alfred Grp SVP Chief Medical Officer | Sell | Biogen Idec Inc. | BIIB | $250.11 | $4M | -50.90% |